| 1 |
34752986 | CD44-targeted, indocyanine green-paclitaxel-loaded human serum albumin nanoparticles for potential image-guided drug delivery. | 2022 Jan |
3 |
| 2 |
35595817 | Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial. | 2022 May 20 |
2 |
| 3 |
33798550 | miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1. | 2021 Jul 1 |
1 |
| 4 |
34004196 | TPGS and chondroitin sulfate dual-modified lipid-albumin nanosystem for targeted delivery of chemotherapeutic agent against multidrug-resistant cancer. | 2021 Jul 31 |
1 |
| 5 |
34278466 | Chemokine CCL20 promotes the paclitaxel resistance of CD44+CD117+ cells via the Notch1 signaling pathway in ovarian cancer. | 2021 Sep |
3 |
| 6 |
34803458 | Investigation of the efficacy of paclitaxel on some miRNAs profiles in breast cancer stem cells. | 2021 |
1 |
| 7 |
32779438 | Overexpression of GATA5 Stimulates Paclitaxel to Inhibit Malignant Behaviors of Hepatocellular Carcinoma Cells. | 2020 Jul |
1 |
| 8 |
33050539 | Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy. | 2020 Oct 10 |
1 |
| 9 |
33692661 | Endothelial Regulation of Drug Transport in a 3D Vascularized Tumor Model. | 2020 Nov 25 |
1 |
| 10 |
30818864 | Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel. | 2019 Feb 27 |
1 |
| 11 |
31460017 | A Composite of Hyaluronic Acid-Modified Graphene Oxide and Iron Oxide Nanoparticles for Targeted Drug Delivery and Magnetothermal Therapy. | 2019 May 31 |
3 |
| 12 |
31867270 | Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness. | 2019 |
1 |
| 13 |
30112929 | Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria. | 2018 Dec |
2 |
| 14 |
30115698 | CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer. | 2018 Nov 1 |
1 |
| 15 |
30179299 | Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells. | 2018 Nov |
3 |
| 16 |
27842858 | Design, synthesis and evaluation of multi-functional tLyP-1-hyaluronic acid-paclitaxel conjugate endowed with broad anticancer scope. | 2017 Jan 20 |
2 |
| 17 |
28523716 | CD44+ fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling. | 2017 Sep |
2 |
| 18 |
29027133 | Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment. | 2017 Dec |
3 |
| 19 |
32264281 | Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy. | 2017 Nov 28 |
2 |
| 20 |
32264448 | Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy. | 2017 Aug 21 |
1 |
| 21 |
26851390 | Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. | 2016 Apr |
1 |
| 22 |
27045981 | CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. | 2016 Jul 1 |
2 |
| 23 |
27255186 | Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitro. | 2016 Jun 3 |
1 |
| 24 |
27305935 | Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. | 2016 Jul 11 |
1 |
| 25 |
27462592 | The effect of salinomycin on ovarian cancer stem-like cells. | 2016 Jul |
2 |
| 26 |
27796093 | CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery. | 2016 Dec 5 |
2 |
| 27 |
25890771 | Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer. | 2015 |
1 |
| 28 |
26117979 | Innovative therapy of ovarian cancer based on overexpression of CD44 receptor. | 2015 May |
1 |
| 29 |
26300335 | Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid. | 2015 Oct |
1 |
| 30 |
26462028 | Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells. | 2015 Nov 10 |
1 |
| 31 |
23681900 | CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients. | 2014 Sep |
1 |
| 32 |
22341413 | Paclitaxel-hyaluronan hydrosoluble bioconjugate: mechanism of action in human bladder cancer cell lines. | 2013 Oct |
1 |
| 33 |
23108794 | Isolation and genomic characterization of stem cells in head and neck cancer. | 2013 Nov |
1 |
| 34 |
23368632 | Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures. | 2013 Jan 31 |
1 |
| 35 |
23500524 | ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel. | 2013 Jun |
2 |
| 36 |
23624503 | Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells. | 2013 May 17 |
8 |
| 37 |
23792807 | Functionalized nanospheres for targeted delivery of paclitaxel. | 2013 Nov 10 |
1 |
| 38 |
24002934 | Paclitaxel-hyaluronic nanoconjugates prolong overall survival in a preclinical brain metastases of breast cancer model. | 2013 Nov |
1 |
| 39 |
24036854 | Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug. | 2013 Nov 15 |
1 |
| 40 |
22309939 | Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells. | 2012 Feb 6 |
1 |
| 41 |
22350800 | Hyaluronan oligomers-HPMA copolymer conjugates for targeting paclitaxel to CD44-overexpressing ovarian carcinoma. | 2012 Apr |
6 |
| 42 |
22581025 | Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines. | 2012 Aug |
1 |
| 43 |
21196304 | DNA methyltransferase inhibitor CDA-2 synergizes with high-dose thiotepa and paclitaxel in killing breast cancer stem cells. | 2011 Jan 1 |
2 |
| 44 |
21935404 | Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms. | 2011 |
1 |
| 45 |
20332234 | Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. | 2010 Apr 1 |
2 |
| 46 |
20428807 | Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells. | 2010 Jun |
1 |
| 47 |
20549538 | Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line. | 2010 Nov |
1 |
| 48 |
18828019 | Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines. | 2009 May |
1 |
| 49 |
19772851 | P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil. | 2009 Nov |
2 |
| 50 |
19823672 | NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance. | 2009 Oct 12 |
3 |